Your session is about to expire
← Back to Search
Behavioural Intervention
BFR plus IRT Group for Parkinson's Disease
N/A
Waitlist Available
Led By Anjali Sivaramakrishnan, PhD, PT
Research Sponsored by The University of Texas Health Science Center at San Antonio
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
1. Males and females between the ages 40 - 85 with a diagnosis of idiopathic Parkinson's Disease (PD) consistent with the United Kingdom PD society brain bank criteria
2. in Hoehn and Yahr stage 2-4
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline to14 weeks
Awards & highlights
Summary
This study is being done to understand how reducing blood flow (BRT) during balance-challenging strengthening exercises (instability resistance training, or IRT) can help improve symptoms of Parkinson's disease.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline to14 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline to14 weeks
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Feasibility metric
Secondary study objectives
Ankle plantar flexor muscle strength
Balance Measure
Functional Mobility
+6 moreTrial Design
2Treatment groups
Experimental Treatment
Group I: IRT Only Control GroupExperimental Treatment1 Intervention
Instability Resistance Training only group. Participants will receive 2 sessions per week over 6 weeks.
Group II: BFR plus IRT GroupExperimental Treatment2 Interventions
Blood Flow Restriction plus Instability Resistance Training group. Participants will receive 2 sessions per week over 6 weeks.
Find a Location
Who is running the clinical trial?
The University of Texas Health Science Center at San AntonioLead Sponsor
466 Previous Clinical Trials
92,068 Total Patients Enrolled
National Institute on Aging (NIA)NIH
1,723 Previous Clinical Trials
28,045,598 Total Patients Enrolled
Anjali Sivaramakrishnan, PhD, PTPrincipal InvestigatorThe University of Texas Health Science Center at San Antonio
Share this study with friends
Copy Link
Messenger